Table 3.

Change in intensity of symptoms from baseline to each visit for patients from the effectiveness population with moderate to severe LUTS at baseline.

	At baseline (n = 164)
	Moderate symptoms	Severe symptoms
At week 24 (n = 144)
(P < 0.001* versus baseline)
No symptoms	0 (0%)	0 (0%)
Mild symptoms	34 (23.6%)	3 (2.1%)
Moderate symptoms	91 (63.2%)	10 (6.9%)
Severe symptoms	1 (0.7%)	5 (3.5%)
At week 48 (n = 137)
(P < 0.001* versus baseline)
No symptoms	1 (0.7%)	1 (0.7%)
Mild symptoms	43 (31.4%)	1 (0.7%)
Moderate symptoms	75 (54.7%)	11 (8.0%)
Severe symptoms	3 (2.2%)	2 (1.5%)
At last available visit (n = 164)
(P < 0.001* versus baseline)
No symptoms	1 (0.6%)	1 (0.6%)
Mild symptoms	51 (31.1%)	2 (1.2%)
Moderate symptoms	88 (53.7%)	14 (8.5%)
Severe symptoms	3 (1.8%)	4 (2.4%)

^*Bhapkar's test for homogeneity.